Paediatric Consumer Health in Colombia

2020 IMPACT

Trusted paediatric consumer health experience upturn in demand during initial stages of pandemic

While there was limited interaction between children over much of 2020 due to lockdown restrictions, a number of paediatric consumer health products still experienced an upturn in demand due to a certain level of initial stockpiling amongst Colombian parents as the pandemic emerged. This supported demand for the largest value category of paediatric analgesics in addition to paediatric cough/cold remedies as local parents traditionally consider these products as safe and effective in treating mild symptoms.

Increasing counterfeits and illegal market concern Colombian parents

Rising cases of counterfeit products and an illegal market towards the end of the review period resulted in increasing concerns amongst local parents regarding the validity of some paediatric consumer health products. The black market tends to include paediatric products in syrup format offered at lower prices which are often smuggled into the country.

GlaxoSmithKline strengthens dominance with wide product portfolio

GlaxoSmithKline strengthened its dominance of paediatric consumer health in 2020, with the player continuing to benefit from a large product portfolio covering different categories following the 2018 merger with Pfizer. While Dolex is a strong leader, GSK Consumer Healthcare also offers notable brands such as Emulsión de Scott, Advil Children and Z-bec.

Files are delivered directly into your account within a few minutes of purchase.